These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8695167)

  • 1. 99mTc-dextran-antibody conjugates. Labelling procedures.
    Márquez M; Westlin JE; Nilsson S; Holmberg AR
    Acta Oncol; 1996; 35(4):489-92. PubMed ID: 8695167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experiments on a new phosphine-peptide chelator for labelling of peptides with Tc-99m.
    Santimaria M; Blok D; Feitsma RI; Mazzi U; Pauwels EK
    Nucl Med Biol; 1999 Apr; 26(3):251-8. PubMed ID: 10363795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of reduction-mediated labelling of antibodies with technetium-99m.
    Zhang ZM; Ballinger JR; Sheldon K; Boxen I
    Int J Rad Appl Instrum B; 1992 Aug; 19(6):607-9. PubMed ID: 1522015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Labeling of polypeptides with technetium-99m using a dextran spacer.
    Holmberg A; Marquez M; Westlin JE; Nilsson S
    Cancer Res; 1995 Dec; 55(23 Suppl):5710s-5713s. PubMed ID: 7493332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technetium-99m labelling of glycosylated somatostatin-14.
    Du J; Hiltunen J; Marquez M; Nilsson S; Holmberg AR
    Appl Radiat Isot; 2001 Aug; 55(2):181-7. PubMed ID: 11393758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organometallic 99mTc(III) '4 + 1' bombesin(7-14) conjugates: synthesis, radiolabeling, and in vitro/in vivo studies.
    Kunstler JU; Veerendra B; Figueroa SD; Sieckman GL; Rold TL; Hoffman TJ; Smith CJ; Pietzsch HJ
    Bioconjug Chem; 2007; 18(5):1651-61. PubMed ID: 17663527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a dextran kit for labelling with 99mTc and its evaluation for lymphoscintigraphy.
    Dass RS; Singh AK; Chauhan UP
    Nucl Med Biol; 1993 Jul; 20(5):701-6. PubMed ID: 7689385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technetium labeling of dextran incorporating cysteamine as a ligand.
    Matsunaga K; Hara K; Imamura T; Fujioka T; Takata J; Karube Y
    Nucl Med Biol; 2005 Apr; 32(3):279-85. PubMed ID: 15820763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting chemistry of reduction-mediated 99mTc-labelling of monoclonal antibodies and polyclonal human immunoglobulins.
    Boonkitticharoen V; Puchinda D; Ayudhya AN; Kraiphibul P
    J Med Assoc Thai; 2001 Apr; 84(4):545-53. PubMed ID: 11460967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct 99mTc labeling of monoclonal antibodies: radiolabeling and in vitro stability.
    Garron JY; Moinereau M; Pasqualini R; Saccavini JC
    Int J Rad Appl Instrum B; 1991; 18(7):695-703. PubMed ID: 1787078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technetium-99m labelling of the anti-tumour antibody PR1A3 by photoactivation.
    Stalteri MA; Mather SJ
    Eur J Nucl Med; 1996 Feb; 23(2):178-87. PubMed ID: 8925853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New (99m)Tc(CO)(3) mannosylated dextran bearing S-derivatized cysteine chelator for sentinel lymph node detection.
    Pirmettis I; Arano Y; Tsotakos T; Okada K; Yamaguchi A; Uehara T; Morais M; Correia JD; Santos I; Martins M; Pereira S; Triantis C; Kyprianidou P; Pelecanou M; Papadopoulos M
    Mol Pharm; 2012 Jun; 9(6):1681-92. PubMed ID: 22519912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation in vitro and in vivo of two labelling techniques of different 99mTc-dextrans for lymphoscintigraphy.
    Wingårdh K; Strand SE
    Eur J Nucl Med; 1989; 15(3):146-51. PubMed ID: 2469580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new 99mTc labelling method for leucocytes: in vitro and in vivo comparison with 99mTc-HMPAO.
    Welling M; Feitsma HI; Blok D; Calame W; Ensing GJ; Goedemans W; Pauwels EK
    Q J Nucl Med; 1995 Jun; 39(2):89-98. PubMed ID: 8574810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetraamine-derived bifunctional chelators for technetium-99m labelling: synthesis, bioconjugation and evaluation as targeted SPECT imaging probes for GRP-receptor-positive tumours.
    Abiraj K; Mansi R; Tamma ML; Forrer F; Cescato R; Reubi JC; Akyel KG; Maecke HR
    Chemistry; 2010 Feb; 16(7):2115-24. PubMed ID: 20066690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complexes of technetium with hydroxycarboxylic acids: gluconic, glucoheptonic, tartaric, and citric.
    Russell CD; Speiser AG
    J Nucl Med; 1980 Nov; 21(11):1086-90. PubMed ID: 7431109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of carrier on 99mTc radiopharmaceuticals.
    Ballinger JR
    Q J Nucl Med; 2002 Sep; 46(3):224-32. PubMed ID: 12134138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality control of 99mTc-labeled dextran for lymphoscintigraphy.
    Yang KT; Jong SB; Wu CC; Chen JY; Chen YJ; Yang LH
    Eur J Nucl Med; 1989; 15(4):171-3. PubMed ID: 2473905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of 99mTc-labelling of recombinant human interleukin-2 via hydrazinonicotinamide.
    Karczmarczyk U; Garnuszek P; Maurin M; Di Gialleonardo V; Galli F; Signore A; Mikołajczak R
    Nucl Med Biol; 2010 Oct; 37(7):795-803. PubMed ID: 20870154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Labelling of the anti-III-neurotubulin monoclonal antibody by 99mTc and its binding to responsible antigen.
    Slapnicková K; Kolárová P; Kynclová K
    Nucl Med Rev Cent East Eur; 2007; 10(1):1-5. PubMed ID: 17694493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.